Back

Clopidogrel or prasugrel vs. aspirin monotherapy for long-term secondary prevention after percutaneous coronary intervention for acute coronary syndrome

28 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy and revascularisation: parallel ways to treat patients with chronic coronary syndromes Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Yoshitaka Iwanaga

National Cerebral & Cardiovascular Center, Suita (Japan)

4 More presentations in this session

Presentation thumbnail
Dual versus single antiplatelet therapy after coronary artery bypass grafting: a meta-analysis of randomized controlled trials
Doctor T. Yoshida (New York, US)
Abstract Slides Video
Presentation thumbnail
Comparative efficacy of clopidogrel and aspirin monotherapy after dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
Doctor N. Ktenopoulos (Athens, GR)
Abstract Slides Video
Presentation thumbnail
The role of ranolazine in managing chronic coronary syndrome: a synthesis of clinical outcomes and health economic modelling
Doctor I. Alhaddad (Amman, JO)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of antithrombotic strategies for atrial fibrillation in patients with chronic coronary syndrome according to coronary treatment strategy: a meta-analysis of randomized trials
Professor Y. Jeong (Gwangmyeong, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy and revascularisation: parallel ways to treat patients with chronic coronary syndromes

The Event

Event poster

ESC Congress 2026

28 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Thirty days clinical outcomes following stent implantation with aspirin-free prasugrel monotherapy in non-ST segment elevation myocardial infarction. Interim report from ASET-Japan pilot study
1 September 2024
thumbnail
Congress Presentation
Safety and efficacy of prolonged antithrombotic therapy in high-risk patients followed in a dedicated secondary prevention consultation
13 May 2024
thumbnail
Congress Presentation
Dual antiplatelet therapy de-escalation followed by aspirin or P2Y12 inhibitor monotherapy after PCI for acute coronary syndrome: a systematic review and meta-analysis
30 August 2025
thumbnail
Congress Presentation
Antiplatelet therapy and prognosis at the onset of stent thrombosis
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources